TB-500 dosing in the glow stack Like BPC-157, TB-500 is present at 10mg per glow stack vial, providing approximately 0.33mg per daily injection
Its interest stems from pre-clinical research showing tissue-repair, anti-inflammatory, cytoprotective and angiogenic effects in animal models
Non-irradiated bacteria, used as control, showed a curved or spiral shape and their bacterial surface appeared intact, with one or a few flagella at one end (Figure 6A)
Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats
Clean your workspace
Research frontiers The main focus of the intervention was that BPC 157 rapidly activates collaterals due to its particular direct and rapid effect on vessel presentation, the bypassing of one or more of the vascular obstructions and thereby achieving a therapeutic effect